Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Insall Scott Kelly Institute for Orthopaedics and Sports Medicine (ISK) is a premier orthopedic group specializing in joint replacement, sports medicine, and spinal care. Founded by pioneers in knee surgery, including Dr. John Insall, the institute is globally recognized for developing the Total Condylar Knee prosthesis and advancing surgical techniques for knee reconstruction. ISK provides a full spectrum of musculoskeletal care, from diagnostic imaging and physical therapy to complex revision surgeries. The institute also operates a highly regarded fellowship program, contributing significantly to clinical research and the education of future orthopedic surgeons. Currently, its primary clinical operations are closely integrated with major hospital systems in the New York metropolitan area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Insall Scott Kelly Institute for Orthopaedics and Sports Medicine.